Jpmorgan Chase & CO Xencor Inc Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding XNCR
# of Institutions
203Shares Held
63.2MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$239 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.12MShares$196 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$151 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$115 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$85.3 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.28B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...